Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NestaCell in Severe COVID-19 Pneumonia
NCT04315987Phase 2Completed
- Sponsor
- Azidus Laboratories Limited
- Start
- Jun 2020
- Primary completion
- Feb 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of NestaCell in COVID-19 pneumonia, sponsored by Azidus Laboratories Limited. Started Jun 2020; status: completed.
02
Drugs
NestaCell
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04315987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04315987.